185 related articles for article (PubMed ID: 9470846)
1. Efficacy and mechanism of aluminium phthalocyanine and its sulphonated derivatives mediated photodynamic therapy on murine tumours.
Chan WS; Brasseur N; La Madeleine C; Ouellet R; van Lier JE
Eur J Cancer; 1997 Oct; 33(11):1855-9. PubMed ID: 9470846
[TBL] [Abstract][Full Text] [Related]
2. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
Chan WS; Brasseur N; La Madeleine C; van Lier JE
Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
[TBL] [Abstract][Full Text] [Related]
3. Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice.
Brasseur N; Ouellet R; La Madeleine C; van Lier JE
Br J Cancer; 1999 Jul; 80(10):1533-41. PubMed ID: 10408394
[TBL] [Abstract][Full Text] [Related]
4. Correlation of distribution of sulphonated aluminium phthalocyanines with their photodynamic effect in tumour and skin of mice bearing CaD2 mammary carcinoma.
Peng Q; Moan J
Br J Cancer; 1995 Sep; 72(3):565-74. PubMed ID: 7669563
[TBL] [Abstract][Full Text] [Related]
5. 31P magnetic resonance spectroscopy as a predictor of efficacy in photodynamic therapy using differently charged zinc phthalocyanines.
Bremner JC; Wood SR; Bradley JK; Griffiths J; Adams GE; Brown SB
Br J Cancer; 1999 Oct; 81(4):616-21. PubMed ID: 10574246
[TBL] [Abstract][Full Text] [Related]
6. Cell and tissue responses of a murine tumour to phthalocyanine-mediated photodynamic therapy.
van Bruggen N; Chan WS; Syha J; Marshall JF; Proctor E; Williams SR; Gadian DG; Hart IR
Eur J Cancer; 1992; 28(1):42-6. PubMed ID: 1567689
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy of tumours with hexadecafluoro zinc phthalocynine formulated in PEG-coated poly(lactic acid) nanoparticles.
Allémann E; Rousseau J; Brasseur N; Kudrevich SV; Lewis K; van Lier JE
Int J Cancer; 1996 Jun; 66(6):821-4. PubMed ID: 8647656
[TBL] [Abstract][Full Text] [Related]
8. Non-monotonic changes in clonogenic cell survival induced by disulphonated aluminum phthalocyanine photodynamic treatment in a human glioma cell line.
Gupta S; Dwarakanath BS; Muralidhar K; Koru-Sengul T; Jain V
J Transl Med; 2010 Apr; 8():43. PubMed ID: 20433757
[TBL] [Abstract][Full Text] [Related]
9. Photocytotoxic efficacy of sulphonated species of aluminium phthalocyanine against cell monolayers, multicellular spheroids and in vivo tumours.
Chan WS; West CM; Moore JV; Hart IR
Br J Cancer; 1991 Nov; 64(5):827-32. PubMed ID: 1931602
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy with phthalocyanine sensitisation: quantitative studies in a transplantable rat fibrosarcoma.
Tralau CJ; MacRobert AJ; Coleridge-Smith PD; Barr H; Bown SG
Br J Cancer; 1987 Apr; 55(4):389-95. PubMed ID: 3580264
[TBL] [Abstract][Full Text] [Related]
11. Targeting of aluminum (III) phthalocyanine tetrasulfonate by use of internalizing monoclonal antibodies: improved efficacy in photodynamic therapy.
Vrouenraets MB; Visser GW; Stigter M; Oppelaar H; Snow GB; van Dongen GA
Cancer Res; 2001 Mar; 61(5):1970-5. PubMed ID: 11280754
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo effects of photodynamic therapy on murine malignant melanoma.
Haddad R; Blumenfeld A; Siegal A; Kaplan O; Cohen M; Skornick Y; Kashtan H
Ann Surg Oncol; 1998; 5(3):241-7. PubMed ID: 9607626
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic activities and biodistribution of fluorinated zinc phthalocyanine derivatives in the murine EMT-6 tumour model.
Allémann E; Brasseur N; Kudrevich SV; La Madeleine C; van Lier JE
Int J Cancer; 1997 Jul; 72(2):289-94. PubMed ID: 9219835
[TBL] [Abstract][Full Text] [Related]
14. Biological activities of phthalocyanines. XVII histopathologic evidence for different mechanisms of EMT-6 tumor necrosis induced by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin.
Margaron P; Madarnas P; Quellet R; Van Lier JE
Anticancer Res; 1996; 16(2):613-20. PubMed ID: 8687105
[TBL] [Abstract][Full Text] [Related]
15. On the photodynamic therapy action spectrum of zinc phthalocyanine tetrasulphonic acid in vivo.
Griffiths J; Cruse-Sawyer J; Wood SR; Schofield J; Brown SB; Dixon B
J Photochem Photobiol B; 1994 Aug; 24(3):195-9. PubMed ID: 7646616
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance spectroscopic studies on 'real-time' changes in RIF-1 tumour metabolism and blood flow during and after photodynamic therapy.
Bremner JC; Bradley JK; Stratford IJ; Adams GE
Br J Cancer; 1994 Jun; 69(6):1083-7. PubMed ID: 8198974
[TBL] [Abstract][Full Text] [Related]
17. Phthalocyanine fluorescence in tumors during PDT.
Moan J; Anholt H
Photochem Photobiol; 1990 Mar; 51(3):379-81. PubMed ID: 2356234
[TBL] [Abstract][Full Text] [Related]
18. Enhanced photodynamic destruction of a transplantable fibrosarcoma using photochemical internalisation of gelonin.
Dietze A; Peng Q; Selbo PK; Kaalhus O; Müller C; Bown S; Berg K
Br J Cancer; 2005 Jun; 92(11):2004-9. PubMed ID: 15886704
[TBL] [Abstract][Full Text] [Related]
19. Hexadecafluorinated zinc phthalocyanine: photodynamic properties against the EMT-6 tumour in mice and pharmacokinetics using 65Zn as a radiotracer.
Boyle RW; Rousseau J; Kudrevich SV; Obochi M; van Lier JE
Br J Cancer; 1996 Jan; 73(1):49-53. PubMed ID: 8554982
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy mediated by aluminium-phthalocyanine nanoemulsion eliminates primary tumors and pulmonary metastases in a murine 4T1 breast adenocarcinoma model.
Rodrigues MC; Vieira LG; Horst FH; de Araújo EC; Ganassin R; Merker C; Meyer T; Böttner J; Venus T; Longo JPF; Chaves SB; Garcia MP; Estrela-Lopis I; Azevedo RB; Muehlmann LA
J Photochem Photobiol B; 2020 Mar; 204():111808. PubMed ID: 32006892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
